Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$971K Buy
11,481
+206
+2% +$16.5K ﹤0.01% 593
2026
Q1
$944K Buy
11,275
+700
+7% +$52.7K ﹤0.01% 622
2025
Q4
$709K Sell
10,575
-24,219
-70% -$1.57M ﹤0.01% 620
2025
Q3
$2.35M Sell
34,794
-415
-1% -$30.1K 0.01% 481
2025
Q2
$2.62M Buy
35,209
+279
+0.8% +$18.6K 0.02% 457
2025
Q1
$2.2M Buy
34,930
+1,410
+4% +$87.2K 0.01% 477
2024
Q4
$1.91M Buy
33,520
+4,224
+14% +$250K 0.01% 517
2024
Q3
$1.72M Buy
29,296
+263
+0.9% +$14.4K 0.01% 517
2024
Q2
$1.57M Buy
29,033
+112
+0.4% +$6.17K 0.01% 525
2024
Q1
$1.67M Buy
28,921
+1,965
+7% +$101K 0.01% 537
2023
Q4
$1.29M Sell
26,956
-7,764
-22% -$370K 0.01% 551
2023
Q3
$1.78M Sell
34,720
-18,862
-35% -$999K 0.01% 464
2023
Q2
$3.07M Sell
53,582
-21,957
-29% -$1.28M 0.02% 422
2023
Q1
$4.19M Sell
75,539
-80
-0.1% -$4.89K 0.03% 405
2022
Q4
$4.44M Buy
75,619
+31,944
+73% +$2.02M 0.03% 408
2022
Q3
$2.5M Sell
43,675
-5,063
-10% -$295K 0.02% 534
2022
Q2
$2.64M Buy
48,738
+1,743
+4% +$101K 0.02% 443
2022
Q1
$2.7M Buy
+46,995
New +$2.4M 0.02% 481
2021
Q4
Sell
-21,877
Closed -$921K 816
2021
Q3
$921K Sell
21,877
-2,761
-11% -$119K 0.01% 717
2021
Q2
$1.09M Sell
24,638
-15,769
-39% -$729K 0.01% 705
2021
Q1
$1.5M Hold
40,407
0.01% 569
2020
Q4
$1.56M Sell
40,407
-22,236
-35% -$795K 0.01% 581
2020
Q3
$1.8M Sell
62,643
-4,921
-7% -$139K 0.02% 521
2020
Q2
$1.81M Sell
67,564
-22,469
-25% -$585K 0.02% 505
2020
Q1
$2.6M Hold
90,033
0.03% 488
2019
Q4
$2.66M Buy
90,033
+60,505
+205% +$1.6M 0.03% 502
2019
Q3
$827K Sell
29,528
-69,786
-70% -$2.02M 0.01% 637
2019
Q2
$2.92M Buy
+99,314
New +$2.67M 0.04% 437

Other funds holding CTVA

Candriam SCA's CTVA Position: Q2 2026 in Review

Candriam SCA increased its Corteva (CTVA) stake by 1.8% in Q2 2026, buying an estimated $16.5K and bringing the position to 11,481 shares worth $971K. The position accounts for ﹤0.01% of the portfolio, ranked #593.

Candriam SCA first reported a position in CTVA in Q2 2019 and has held it in 28 quarters since. The position peaked at $4.44M in Q4 2022. 1,489 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Candriam SCA held 11,481 shares of Corteva worth $971K as of Q2 2026.
  • Candriam SCA bought 206 Corteva shares in Q2 2026, an estimated $16.5K.
  • Corteva made up ﹤0.01% of Candriam SCA's portfolio in Q2 2026, its #593 holding.
  • Candriam SCA first reported a position in Corteva in Q2 2019 and has held it in 28 quarters since.
  • Candriam SCA's Corteva position peaked at $4.44M in Q4 2022.
  • 1,489 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.